Workflow
Hubei Chaozhuo Aviation Technology (688237)
icon
Search documents
超卓航科:中航证券有限公司关于湖北超卓航空科技股份有限公司暂时调整募投项目闲置场地用途的核查意见
2023-08-15 11:05
中航证券有限公司 为规范募集资金的管理和使用,提高资金使用效率和效益,保护投资者利益, 公司按照《中华人民共和国公司法》、《上海证券交易所科创板股票上市规则》、 关于湖北超卓航空科技股份有限公司 暂时调整募投项目闲置场地用途的核查意见 中航证券有限公司(以下简称"中航证券"或"保荐机构")作为湖北超卓 航空科技股份有限公司(以下简称"超卓航科"或"公司")首次公开发行股票 并在科创板上市的保荐机构和持续督导机构,根据《证券发行上市保荐业务管理 办法》《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求》 《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等有关法 律、法规的规定,对超卓航科暂时调整募投项目闲置场地用途事项进行了认真、 审慎的核查,并发表核查意见如下: 一、募集资金基本情况 中国证券监督管理委员会于 2022 年 4 月 22 日核发《关于同意湖北超卓航空 科技股份有限公司首次公开发行股票注册的批复》(证监许可[2022]850 号),同 意公司首次公开发行 A 股股票(以下简称"本次发行")。公司本次发行的股份 数量为 2,240.0828 万股,发行价格为每股 ...
超卓航科:超卓航科关于暂时调整募投项目闲置场地用途的公告
2023-08-15 11:05
本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 证券代码:688237 证券简称:超卓航科 公告编号:2023-026 湖北超卓航空科技股份有限公司 关于暂时调整募投项目闲置场地用途的公告 一、募集资金基本情况 中国证券监督管理委员会于 2022 年 4 月 22 日核发《关于同意湖北超卓航空 科技股份有限公司首次公开发行股票注册的批复》(证监许可[2022]850 号),同 意公司首次公开发行 A 股股票(以下简称"本次发行")。公司本次发行的股份数 量为 2,240.0828 万股,发行价格为每股 41.27 元,募集资金总额为人民币 92,448.22 万元,实际募集资金净额为人民币 80,857.59 万元。上述募集资金全部于 2022 年 6 月 28 日到账,已经天职国际会计师事务所(特殊普通合伙)审验并出具天职 业字[2022]35475 号《验资报告》。 募集资金到账后,公司对募集资金进行了专户存储,并与保荐机构、存放募 集资金的银行签署了募集资金专户存储监管协议。 (二)募集资金的使用情况 二、募集资金管理 ...
超卓航科(688237) - 2023 Q1 - 季度财报
2023-04-28 16:00
Financial Performance - The company's operating revenue for Q1 2023 was ¥60,050,139.24, representing a year-on-year increase of 40.54%[5] - The net profit attributable to shareholders decreased by 16.62% to ¥21,488,686.10 compared to the same period last year[5] - Basic and diluted earnings per share both stood at ¥0.24, down 37.47% year-on-year[6] - Total operating revenue for Q1 2023 reached ¥60,050,139.24, a 40.5% increase from ¥42,728,647.65 in Q1 2022[22] - Net profit for Q1 2023 was ¥21,488,686.10, a decrease of 16.7% compared to ¥25,771,076.91 in Q1 2022[23] - Total comprehensive income for Q1 2023 was ¥21,488,686.10, down from ¥25,771,076.91 in Q1 2022[24] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,459,151,853.66, reflecting a slight increase of 0.91% from the end of the previous year[6] - Total liabilities as of Q1 2023 amounted to ¥146,432,190.65, a decrease from ¥154,766,387.75 in the previous year[19] - Total equity attributable to shareholders reached ¥1,312,719,663.02, up from ¥1,291,230,976.92 in Q1 2022[19] - The company's total assets as of March 31, 2023, amounted to RMB 1,459,151,853.66, an increase from RMB 1,445,997,364.67 as of December 31, 2022[16] Cash Flow - The net cash flow from operating activities was negative at -¥455,777.68, a decline of 101.73% compared to the previous year[5] - Cash inflow from operating activities totaled $60,174,646.14, compared to $46,660,751.35 in the previous year[27] - Cash outflow for purchasing goods and services was $32,503,393.98, significantly higher than $10,477,275.37 in the previous year[27] - The net cash flow from investment activities was -$52,657,725.54, an improvement from -$95,988,691.83 in the previous year[27] - The ending balance of cash and cash equivalents was $259,205,675.58, a decrease from $44,018,546.29 year-over-year[28] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 4,492[12] - The top three shareholders held a combined 49.77% of the company's shares, with the largest shareholder owning 22.67%[12] - The company’s major shareholders include Li Yihan, Li Guangping, and Wang Chunxiao, with Li Guangping and Wang Chunxiao being spouses[14] - The company has a 6.33% stake held by Aviation Industry Group through its subsidiary, indicating significant institutional investment[14] Research and Development - Research and development expenses totaled ¥3,034,275.06, accounting for 5.05% of operating revenue, a decrease of 1.86 percentage points year-on-year[6] - Research and development expenses for Q1 2023 were ¥3,034,275.06, slightly up from ¥2,953,189.32 in Q1 2022[22] Market Strategy - The company is focused on expanding its market presence and enhancing its product offerings through strategic investments and partnerships[14]
超卓航科:超卓航科关于召开2022年度暨2023年第一季度业绩说明会的公告
2023-04-28 07:48
证券代码:688237 证券简称:超卓航科 公告编号:2023-012 湖北超卓航空科技股份有限公司 关于召开 2022 年度暨 2023 年第一季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示: http://roadshow.sseinfo.com/) 会议召开方式:上证路演中心网络互动 投资者可于 2023 年 05 月 04 日(星期四)至 05 月 10 日(星期三)16:00 前登 录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 hbcz@cz- tec.com 进行提问。公司将在说明会上对投资者普遍关注的问题进行回答。 湖北超卓航空科技股份有限公司(以下简称"公司")已于 2023 年 4 月 20 日发布公司 2022 年年度报告,于 2023 年 4 月 29 日发布公司 2023 年第一季度 报告,为便于广大投资者更全面深入地了解公司 2022 年及 2023 年第一季度经 营成果、财务状况及 2022 年度利润分配情况,公司计划于 2023 年 5 月 ...
超卓航科(688237) - 2022 Q4 - 年度财报
2023-04-19 16:00
Financial Performance - The company achieved a net profit attributable to shareholders of RMB 59,086,007.70 for the year 2022[7]. - The profit distribution plan for 2022 is to not distribute profits and not to convert capital reserves into share capital[7]. - The company has not yet achieved profitability since its listing[4]. - The company's operating revenue for 2022 was ¥139,704,605.04, a decrease of 1.13% compared to ¥141,305,811.33 in 2021[22]. - The net profit attributable to shareholders for 2022 was ¥59,086,007.70, down 16.46% from ¥70,731,115.18 in 2021[22]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥41,720,744.52, a decline of 30.66% compared to ¥60,172,240.15 in 2021[22]. - Basic earnings per share for 2022 were ¥0.75, a decrease of 28.57% from ¥1.05 in 2021[24]. - The cash flow from operating activities for 2022 was ¥49,028,207.22, a slight increase of 0.73% from ¥48,671,888.42 in 2021[22]. - The company experienced a significant increase in costs, particularly in raw materials and sales expenses, impacting profitability[25]. - The total amount of non-recurring gains and losses for 2022 was 17.37 million yuan, compared to 10.56 million yuan in 2021[30]. Assets and Liabilities - The company's total assets increased by 207.19% to ¥1,445,997,364.67 at the end of 2022, compared to ¥470,723,125.72 at the end of 2021[23]. - The net assets attributable to shareholders rose by 205.08% to ¥1,291,230,976.92 at the end of 2022, compared to ¥423,241,604.87 at the end of 2021[23]. - The company's cash and cash equivalents increased by 190.56% to ¥337,738,450.53, accounting for 23.36% of total assets[142]. - Accounts receivable rose by 52.15% to ¥89,156,436.03, representing 6.17% of total assets, primarily due to the addition of a new holding company[142]. - The company reported a significant increase in inventory by 125.66% to ¥65,985,101.43, which accounted for 4.56% of total assets[142]. - The company's total liabilities increased significantly, with a notable rise in contract liabilities to ¥21,864,573.68, reflecting a growth of 10,629.84%[144]. Research and Development - The R&D expenditure as a percentage of operating revenue increased to 10.98% in 2022 from 9.13% in 2021, reflecting a growth of 1.85 percentage points[24]. - The company increased its investment in R&D and market expansion, focusing on customized additive manufacturing technologies, particularly cold spraying[35]. - In 2022, the company's R&D expenses amounted to CNY 15.33 million, representing a year-on-year increase of 18.91%, maintaining a high R&D expense ratio of 10.98%[40]. - The company has developed 9 core technologies and obtained 50 patents, focusing on optimizing existing technologies and expanding applications in cold spray solid additive manufacturing[84]. - The company applied for 50 new patents during the reporting period, including 32 invention patents and 14 utility model patents, bringing the total to 137 applications and 60 granted patents[89]. Market and Business Strategy - The company is focused on additive manufacturing technologies, including cold spray technology[13]. - The company has outlined its future plans and development strategies, which are subject to investment risks[8]. - The company is actively exploring new application fields for cold spraying technology, targeting both military and civilian markets[36]. - The company has established preliminary cooperation intentions with a client under AVIC for weapon shell trial production, marking a significant breakthrough in applying customized additive manufacturing technology[37]. - The company is shifting its R&D focus from basic material development to engineering research on process technology, with plans to increase R&D investment and enhance its innovation capabilities[41]. Governance and Compliance - The company has received a standard unqualified audit report from Tianzhi International Accounting Firm[6]. - There are no non-operating fund occupations by controlling shareholders or other related parties[9]. - The company does not have any special arrangements for corporate governance[10]. - The company has established a comprehensive quality control system, including various management manuals to ensure compliance with production and service quality standards[51]. - The company has military and civil product qualifications, which are subject to high entry barriers, ensuring a competitive advantage in the market[105]. Risks and Challenges - The report includes a detailed discussion of various risks faced by the company and corresponding countermeasures[4]. - The company faces risks related to the commercialization of its cold spray solid additive manufacturing technology, which is still in a developmental stage domestically[108]. - There is a high concentration risk with major customers, as the top five customers account for a significant portion of the company's revenue[112]. - The company is exposed to risks from overseas procurement, particularly for high-purity helium and metal powders, which are primarily sourced from foreign suppliers[110]. - The company is at risk of core technical personnel turnover, which could adversely affect technology development and new product research[109]. Employee and Management Structure - The total number of employees in the parent company and major subsidiaries is 319, with 114 in the parent company and 205 in subsidiaries[200]. - The educational background of employees includes 10 with master's degrees or above, 58 with bachelor's degrees, and 251 with associate degrees or below[200]. - The average age of R&D personnel is predominantly between 30-40 years, with 29 individuals in this age group, indicating a relatively young and dynamic team[99]. - The company has a diverse board with a mix of genders and ages, enhancing its governance structure[181]. - The company is focused on retaining key technical personnel to drive innovation and development[181].
超卓航科(688237) - 2022 Q2 - 季度财报
2022-08-29 16:00
Financial Performance - The company's operating revenue increased by 21.26% year-on-year, attributed to enhanced market development and expanded sales [19]. - Basic earnings per share for the reporting period was CNY 0.54, up 5.88% from CNY 0.51 in the same period last year [19]. - The weighted average return on net assets decreased to 8.24%, down 0.97 percentage points compared to 9.21% in the previous year [19]. - The diluted earnings per share remained at CNY 0.54, consistent with the basic earnings per share [19]. - The net profit margin after deducting non-recurring gains and losses was CNY 0.40 per share, reflecting a 2.56% increase from CNY 0.39 [19]. - Net profit attributable to shareholders increased by 6.96% year-on-year, amounting to ¥36,384,900.18 [21]. - Revenue for the reporting period reached ¥73,947,440.09, representing a 21.26% increase compared to the same period last year [21]. - The company reported a total revenue of 4,102.00 million RMB, with a net profit of 623.60 million RMB for the first half of 2022 [59]. - The total profit for the first half of 2022 was ¥42,279,186.24, compared to ¥39,137,384.18 in the same period of 2021, showing overall growth [171]. Research and Development - Research and development expenses accounted for 8.43% of operating revenue, a decrease of 1.07 percentage points from 9.50% [19]. - The total R&D expenditure for the reporting period was ¥6,235,711.39, an increase of 7.67% compared to ¥5,791,695.63 in the same period last year [54]. - R&D expenses increased by 7.67% year-on-year, with a focus on new product development and talent acquisition, leading to the initiation of multiple new R&D projects [68]. - The company has developed 9 core technologies and obtained 34 patents, focusing on advanced additive manufacturing techniques for aerospace applications [50]. - The company applied for 25 new patents during the reporting period, with 14 patents granted, bringing the total to 102 applications and 44 granted patents [52]. - The company is currently working on five major R&D projects, with total expected investments of ¥1,800 million [56]. Market Position and Strategy - The company is the sole supplier for fatigue crack repair of various models of fighter jet landing gear beams for military maintenance [27]. - The company has established a dedicated R&D center to drive technological advancements and optimize production processes, aligning with market needs [30]. - The company operates under a "make-to-order" production model, ensuring production aligns with customer-specific demands and delivery timelines [32]. - The company has established deep cooperative relationships with major clients, including military units and domestic airlines, enhancing its market reputation [70]. - The company is focused on expanding its market presence through technological advancements and strategic partnerships in the aerospace sector [50]. - The company aims to meet the increasing demand for aircraft component repairs, particularly for military applications, through its innovative technologies [51]. Cash Flow and Assets - Net cash flow from operating activities increased by 31.35% year-on-year, primarily due to a significant increase in cash received from sales of goods and services [20]. - Total assets at the end of the reporting period amounted to CNY 1,365,000,000, with cash and cash equivalents constituting 64.43% of total assets [94]. - The company's cash and cash equivalents increased significantly to ¥879,637,920.33 from ¥116,238,406.82, representing a growth of approximately 655.5% [162]. - Total current assets reached ¥1,014,345,066.35, up from ¥220,739,444.42, marking a substantial increase of approximately 359.5% [162]. - The company's fixed assets grew to ¥73,861,738.82 from ¥64,990,497.66, reflecting an increase of around 13.6% [162]. Risks and Compliance - The company has detailed various risks and countermeasures in the report, emphasizing the importance of risk awareness for investors [4]. - The company faces risks related to the commercialization of its cold spraying technology, as domestic applications are still in the developmental stage compared to international standards [78]. - The company anticipates potential revenue fluctuations due to the uncertainty of military pricing adjustments, which could adversely affect profitability [83]. - The company has committed to enhancing its governance structure and operational compliance to support its business objectives and maintain competitive advantages [77]. Shareholder Information - The total number of shares increased from 67,202,482 to 89,603,310 after the issuance of 22,400,828 new shares [143]. - The largest shareholder, Li Yihan, holds 20,315,197 shares, representing 22.67% of total shares [149]. - The company has a diverse shareholder base, including both individual and institutional investors [150]. - The report indicates no pledged, marked, or frozen shares among the top shareholders [149]. - Major shareholders will return their after-tax cash dividends to the company if they fail to fulfill share repurchase commitments [130].